Lilly (Eli) & Co Dividend yield




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   USD per share 
 Price  84.64
 Dividend  2.08
 Earnings  3.10
 Cash-flow  4.39
 Book value  12.63
 Equity  12.92

Lilly (Eli) & Co is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Lilly (Eli) & Co is a company from USA, and his stocks are publicly traded.

Lilly (Eli) & Co paid a total dividend of 2,294 million USD last year, for a market value of 93,358 millions (Market Cap 82,528 millions). Dividend per share of Lilly (Eli) & Co is 2.08 USD, and his stock market price 84.64 USD.

According to the chart below, where dividend yield is displayed, Lilly (Eli) & Co has a dividend yield of 2.46%, which is higher than the amount offered by both the market average and companies from USA. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Lilly (Eli) & Co dividend yield with other Pharmaceuticals and Biotechnology companies or firms from USA.

Dividend yield of Lilly (Eli) & Co

Lilly (Eli) & Co Dividend Payout

About the ability of Lilly (Eli) & Co to maintain his current dividend of USD 2.08 per share, an amount that accounts for 2.46%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Lilly (Eli) & Co payout on ernings is currently 67.10%, which is higher than the market average, and companies of Health Care industry, which are 39.11% and 28.64% respectively. Both figures show that Lilly (Eli) & Co can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Lilly (Eli) & Co is USD 4.39 per share, which is higher than the dividend per share paid by the company of USD 2.08, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Lilly (Eli) & Co, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies. You might also need to check full financial report of Lilly (Eli) & Co.

Lilly (Eli) & Co payout

Lilly (Eli) & Co Stock performance

Finally, last moth Lilly (Eli) & Co showed a return of 3.30% compared to a worldwide 0.15% average, and a 0.79% of Health Care firms. Over the last year, the company obtained a 26.10% versus a worldwide performance of a 19.92%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.

Lilly (Eli) & Co stock and market return

Next companies

Lincoln National Cor. USA. Financials.

Linde. Germany. Basic Materials.

Lindt & Spruengli-PC. Switzerland. Consumer Goods.

LINE. Japan. Technology.

Linear Technology Co. USA. Technology.

Link Real Estate Inv. Hong-Kong. Financials.

Previous companies

Lifestyle International. Hong-Kong. Consumer Services.

Lifestyle China Grou. Hong-Kong. Consumer Services.

Life Healthcare Grou. South Africa. Health Care.

LIC Housing Finance. India. Financials.

Liberty Ventures Cla. USA. Financials.

LIBERTY SIRIUSXM SER. USA. Consumer Services.

 

 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.